Clinical Trial Update: Phase 2, Safety & Microbiology Study of C16G2 in Multiple Oral Gel &/or Mouth Rinse Doses to Healthy Adults [Phase 2]

View source ↗

Summary

Phase 2 safety and microbiology study of C16G2 in healthy adults completed for dental caries indications.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dental Caries

Drugs mentioned

• C16G2

Snippet

Sponsor: Armata Pharmaceuticals, Inc. | Conditions: Dental Caries | Phase 2 | Status: COMPLETED